Market Overview:
The global ciprofloxacin ophthalmic solution market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of eye infections and rising demand for ciprofloxacin ophthalmic solution products. Based on type, the global ciprofloxacin ophthalmic solution market is segmented into 2.5ml/bottle, 5ml/bottle and 10ml/bottle segments. The 2.5ml/bottle segment is expected to account for a major share of the global ciprofloxacin ophthalmic solution market in 2018 owing to its low price point and easy availability across regions. However, the 10 ml/bottles segment is projected to grow at a higher CAGR during the forecast period as it offers better value for money compared with other types available in the market. Based on application, hospitals are estimated to account for a majority share of the global ciprofloxacin ophthalmic solution market in 2018 followed by clinics.
Product Definition:
Ciprofloxacin ophthalmic solution is a prescription medication used to treat bacterial infections of the eye. It is important because it can help to clear up an infection and prevent it from spreading.
2.5ml/bottle:
2.5ml/bottle, it's usage and growth factor in Ciprofloxacin Ophthalmic Solution market? 2.5 ml of ciprofloxacin ophthalmic solution contains 0.3 mg of ciprofloxacin and is used for the treatment of bacterial keratitis, corneal abrasion, contact lens-related infections.
5ml/bottle:
Ciprofloxacin ophthalmic solution contains 5 ml/bottle and it is used for the treatment of bacterial keratitis, corneal ulcer, staphylococcal scalding eye infection and Toxic Epidemic Keratitis (TEEK).
Application Insights:
Based on the application, the global ciprofloxacin ophthalmic solution market has been segmented into hospital, clinics and recovery centers and other applications. The hospital segment dominated the overall market in terms of revenue in 2017. This is due to a high prevalence of bacterial infections across hospitals that require treatment with antibiotics for cure. Furthermore, increasing investments by governments to improve healthcare infrastructure at a domestic level will boost product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing cases of bacterial conjunctivitis and other associated disorders. In addition, rising awareness about ciprofloxacin-based ophthalmic solutions among patients and physicians is anticipated to propel the demand for these products over the forecast period.
Asia Pacific is expected to witness lucrative growth over the coming years due to factors such as improving healthcare infrastructure, growing penetration of generic drugs, rise in prevalence of infectious diseases like bacterial conjunctivitis and increased focus on quality medical care services by private players & public sector companies. These factors are likely to contribute toward regional market growth during the forecast period from 2018 To 2030 (Ref: World Health Organization (WHO), Global Burden of Disease).
Growth Factors:
- Increasing incidence of eye infections: The increasing incidence of eye infections is one of the key growth drivers for the ciprofloxacin ophthalmic solution market. This is because ciprofloxacin ophthalmic solution is an effective treatment for a wide range of eye infections.
- Rising awareness about the benefits of ciprofloxacin ophthalmic solution: The rising awareness about the benefits of ciprofloxacin ophthalmic solution is another key growth driver for this market. This is because it helps to improve patient compliance rates and also helps to reduce overall treatment costs.
- Growing demand from emerging markets: The growing demand from emerging markets is another key growth driver for this market, as these regions offer high potential growth opportunities due to their large population base and rapidly expanding economies.
- Technological advancements in drug delivery systems: The technological advancements in drug delivery systems are also helping to drive the growth of this market, as they are facilitating the development and commercialization of novel formulations and dosage forms that offer better patient compliance rates and improved efficacy profiles compared to traditional formulations/dosage forms available in this market currently .
Scope Of The Report
Report Attributes
Report Details
Report Title
Ciprofloxacin Ophthalmic Solution Market Research Report
By Type
2.5ml/bottle, 5ml/bottle, 10ml/bottle
By Application
Hospital, Clinics, Recovery Center
By Companies
Akorn, Novartis, Sandoz, Hi-Tech Pharmaceuticals, Falcon Pharmaceuticals, Wellona Pharma, Alcon, Rising Pharmaceuticals, Zhengzhou Zhuofeng Pharmaceutical, Wuhan Wujing Medicine, Shuangke Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Ciprofloxacin Ophthalmic Solution Market Report Segments:
The global Ciprofloxacin Ophthalmic Solution market is segmented on the basis of:
Types
2.5ml/bottle, 5ml/bottle, 10ml/bottle
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Akorn
- Novartis
- Sandoz
- Hi-Tech Pharmaceuticals
- Falcon Pharmaceuticals
- Wellona Pharma
- Alcon
- Rising Pharmaceuticals
- Zhengzhou Zhuofeng Pharmaceutical
- Wuhan Wujing Medicine
- Shuangke Pharm
Highlights of The Ciprofloxacin Ophthalmic Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2.5ml/bottle
- 5ml/bottle
- 10ml/bottle
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ciprofloxacin Ophthalmic Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ciprofloxacin ophthalmic solution is a topical antibiotic that is used to treat bacterial infections of the eye. It is available in a variety of concentrations (from 0.3% to 2%) and forms (drops, ointment, gel). Ciprofloxacin ophthalmic solution is usually applied twice daily to the affected eye.
Some of the key players operating in the ciprofloxacin ophthalmic solution market are Akorn, Novartis, Sandoz, Hi-Tech Pharmaceuticals, Falcon Pharmaceuticals, Wellona Pharma, Alcon, Rising Pharmaceuticals, Zhengzhou Zhuofeng Pharmaceutical, Wuhan Wujing Medicine, Shuangke Pharm.
The ciprofloxacin ophthalmic solution market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ciprofloxacin Ophthalmic Solution Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ciprofloxacin Ophthalmic Solution Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ciprofloxacin Ophthalmic Solution Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ciprofloxacin Ophthalmic Solution Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ciprofloxacin Ophthalmic Solution Market Size & Forecast, 2020-2028
4.5.1 Ciprofloxacin Ophthalmic Solution Market Size and Y-o-Y Growth
4.5.2 Ciprofloxacin Ophthalmic Solution Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2.5ml/bottle
5.2.2 5ml/bottle
5.2.3 10ml/bottle
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ciprofloxacin Ophthalmic Solution Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ciprofloxacin Ophthalmic Solution Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2.5ml/bottle
9.6.2 5ml/bottle
9.6.3 10ml/bottle
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2.5ml/bottle
10.6.2 5ml/bottle
10.6.3 10ml/bottle
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2.5ml/bottle
11.6.2 5ml/bottle
11.6.3 10ml/bottle
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2.5ml/bottle
12.6.2 5ml/bottle
12.6.3 10ml/bottle
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2.5ml/bottle
13.6.2 5ml/bottle
13.6.3 10ml/bottle
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ciprofloxacin Ophthalmic Solution Market: Competitive Dashboard
14.2 Global Ciprofloxacin Ophthalmic Solution Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Akorn
14.3.2 Novartis
14.3.3 Sandoz
14.3.4 Hi-Tech Pharmaceuticals
14.3.5 Falcon Pharmaceuticals
14.3.6 Wellona Pharma
14.3.7 Alcon
14.3.8 Rising Pharmaceuticals
14.3.9 Zhengzhou Zhuofeng Pharmaceutical
14.3.10 Wuhan Wujing Medicine
14.3.11 Shuangke Pharm
